Brief: Shaanxi Micot Pharmaceutical Technology Co Says Phase II Trial Of MT200605 For AIS Reaches Primary Endpoint
03/08/2026 16:33
BRIEF-Shaanxi Micot Pharmaceutical Technology Co Says Phase II Trial Of MT200605 For AIS Reaches Primary Endpoint Aug 3 (Reuters) - Shaanxi Micot Pharmaceutical Technology Co Ltd 2335.HK:
PHASE II TRIAL OF MT200605 FOR AIS REACHES PRIMARY ENDPOINT WITH STATISTICALLY SIGNIFICANT OUTCOMES
Further company coverage: 2335.HK
((Reuters.Briefs@thomsonreuters.com;))